heterogeneous disease consisting of multiple endotypes, a substantial subset of asthma begins in childhood, and the immune changes leading to disease occur early in life. [4] [5] [6] Currently, no prevention strategies exist, and therefore better understanding of the early-life immune changes that contribute to development of disease is critical.
During childhood, allergic sensitization and associated T H 2 cell immune elements are key risk factors for airway inflammation, low lung function, airway hyperresponsiveness, and asthma. [7] [8] [9] [10] Developing sensitization to multiple allergens in the first few years of life is especially important in light of its poor prognosis with respect to persistent disease, increased exacerbations, and low lung function. [11] [12] [13] Although some genetic and environmental risk factors for T H 2 inflammation and asthma development are known, 14, 15 the early-life immune pathways that drive the imbalance toward a T H 2 immune response in human subjects are not well understood. 6 Furthermore, not all subjects in whom allergen-specific T H 2 inflammation develops will experience asthma, and the systemic immunologic changes that specifically predispose to allergic asthma are unclear.
Several innate immune cells, including type 2 innate lymphoid cells, natural killer (NK) cells, invariant natural killer T cells (iNKTs), gd T cells, dendritic cells (DCs), monocytes, and others, can contribute to increased T H 2-type cytokine signaling, and these cells are all key early responders to exogenous antigens and infections. [16] [17] [18] [19] Studies in mouse models have demonstrated the importance of innate immune cells in the development of allergic airway responses, [20] [21] [22] [23] [24] and differences in type 2 innate lymphoid cell, NK cell, and iNKT cell populations have been observed in adults with established asthma. [25] [26] [27] [28] However, demonstration of the innate immune mechanisms that can initiate T H 2 asthma in human subjects is lacking.
To identify immunologic antecedents of allergic sensitization and asthma in early childhood, we studied children enrolled in an ongoing high-risk asthma birth cohort study: Urban Environment and Childhood Asthma (URECA). 29 Enrolled participants all have a parental history of allergic diseases or asthma and live in low-income census tracts. Per study design, the entire cohort had PBMCs collected at age 2 years and were stimulated with dust mite or cockroach extracts, tetanus toxoid (TT), or medium alone (nonstimulated). We used an unbiased whole-genome RNA sequencing approach coupled with cell deconvolution to investigate PBMC gene expression and stimulation responses, and here we report immunologic differences that can be detected at age 2 years and correspond to the development of aeroallergen sensitization and asthma.
METHODS

URECA population
URECA is a birth cohort study initiated in 2005 in inner-city Baltimore, Boston, New York City, and St Louis, and details of the study design have been described elsewhere. 29 In brief, pregnant women age 18 years or older were recruited with selection criteria, including a history of asthma, allergic rhinitis, or eczema, in the mother or father. Between February 2005 and March 2007, 1850 families were screened, 776 met the eligibility criteria, and 560 newborns were enrolled at birth. Informed consent was obtained from the parent or legal guardian of the infant.
Maternal questionnaires were administered prenatally and postnatally every 3 months through age 7 years to ascertain wheezing illnesses and rhinitis symptoms. Allergen-specific IgE (ImmunoCAP; Phadia, Uppsala, Sweden) levels for milk, egg, peanut, and German cockroach were measured yearly until age 7 years. Specific IgE for DMs (Dermatophagoides farinae and Dermatophagoides pteronyssinus), dog, cat, mouse, and Alternaria species was added for ages 2 to 7 years. The lower limit of detection for the specific IgEs was 0.10 kU/L, and we manually set all values that were less than this to be 0.09 kU/L.
Skin prick tests were performed at 3, 5, and 7 years of age for 14 common aeroallergens. Allergen sensitization was defined as either a wheal of 3 mm or greater larger than that elicited by the saline control on skin prick testing or specific IgE levels of 0.35 kU/L or greater.
Asthma at age 7 years was defined by using a prespecified algorithm that included a parent-reported physician's asthma diagnosis, asthma symptoms, health care use for asthma, use of asthma medications in the previous year, spirometry with reversibility, and bronchial hyperresponsiveness assessed by means of methacholine inhalation challenge. Home visits 3 months after birth included house dust collection to assay for the allergens Bla g 1 (cockroach), Can f 1 (dog), Fel d 1 (cat), Der f 1 and Der p 1 (house DMs), and Mus m 1 (mouse) by means of ELISA (Indoor Biotechnologies, Charlottesville, Va).
PBMC processing and stimulation studies
Peripheral blood samples were collected at age 2 years and processed, as previously described. 29 In short, at each URECA research center, within 16 hours of blood collection, 1.0 3 10 6 mononuclear cells were separated and incubated (for 48 hours at 378C in a 5% CO 2 atmosphere) in the presence of German cockroach extract (10 mg/mL; Greer Laboratories, Lenoir NC), DM extract (10 mg/mL; Dermatophagoides pteronyssinus; Greer Laboratories), TT (5 mg/mL; MassBiologics, Mattapan Mass), or medium alone (AIM-V media with human serum albumin; #12055-091; Invitrogen, Carlsbad, Calif). After incubation, cells were lysed with TRIzol (Tri-Reagent LS; Fisher Scientific, Waltham, Mass) and maintained at 2808C pending extraction of total cellular RNA.
Study design
An overview of the study design and analytic flow is presented in Fig E1 in this article's Online Repository at www.jacionline.org. For the initial casecontrol cohort (cohort 1), cases (n 5 21) were URECA participants who met the following inclusion criteria: (1) 2 or more aeroallergen sensitizations at ages 3, 5, and 7 years, including sensitization to DM, cockroach, or both at each age; (2) diagnosis of asthma at age 7 years; and (3) PBMC RNA samples collected at age 2 years. Control subjects (n 5 30) were URECA participants with (1) no aeroallergen sensitization through age 7 years, (2) did not have asthma at age 7 years, and (3) had PBMC RNA samples collected at age 2 years. Control subjects were selected to match to cases on at least a bivariate level, according to the following variables: sex, race, URECA site, birth season, and levels of Bla g 1, Der f 1, and Def p 1 measured in the home 3 months after birth. All available nonstimulated and cockroach-, DM-, and TTstimulated PBMC samples from these 51 subjects were selected for RNA sequencing.
For cohort 2, 7 additional URECA participants were selected who met the following inclusion criteria: (1) 1 or more aeroallergen sensitizations by age 7 years, including cockroach sensitization; (2) a diagnosis of asthma at age 7 years; and (3) PBMC RNA samples collected at age 2 years. Fourteen additional control subjects were selected to match these cases by using the same criteria as the control subjects of cohort 1.
Furthermore, all URECA participants with PBMC RNA samples collected at age 2 years who had sufficient year 7 outcome data for group classification (full cohort) were added to the sequencing run to allow a 4-group comparison based on cockroach sensitization (age 3 years, yes/no) and asthma (age 7 years, yes/no). For the latter analyses, only nonstimulated and cockroachstimulated PBMC samples were used for RNA sequencing.
RNA sequencing
RNA was extracted from TRIzol, according to the manufacturer's protocol. RNA quality was assessed by using RNA electrophoresis (Agilent, Santa Clara, Calif). All samples had RNA integrity number values of 7 or greater. Sequencing libraries were constructed from total RNA by using TruSeq RNA Sample Preparation Kits v2 (Illumina, San Diego, Calif) and clustered onto a flow cell by using a cBOT amplification system with a HiSeq SR v4 Cluster Kit (Illumina). Single-read sequencing was carried out on a HiSeq2500 sequencer (Illumina) by using a HiSeq SBS v4 Kit to generate 58-base reads, with a target of approximately 10 million reads per sample.
Samples were processed in 2 separate batches. Cohort 1 was processed as a single batch. All additional samples (cohort 2 and the full cohort) were processed as a second batch. One half of the samples from cohort 1 had sequencing library preparation and RNA sequencing repeated during the second batch to control for batch effects.
Bioinformatics analysis
FASTQ files were downloaded from https://basespace.illumina.com. Libraries were processed with Galaxy. 30 Libraries were aligned by using TopHat (version 1.4.1) 31 to the human reference genome, Ensembl's Homo sapiens GRCh38, version 77 (GRCh38.77.gtf). The single-paired flag was set to ''single,'' whereas all other TopHat parameters were set to defaults. The HTSeqcount 32 was used to generate gene counts with mode as ''intersection (nonempty),'' and minimum alignment quality was set to 0 and otherwise set to default parameters.
Statistics
Genes with a trimmed mean of M values normalized 33 count of at least 1 in 20% of libraries and a gene biotype 34 of protein coding went into further analysis, leaving 13,867 Ensembl IDs that went into further analysis. Count data were converted into log 2 counts per million while weighting the observations to estimate the mean-variance relationship and incorporating the correlation between samples from the same subject by using the voom function 35 in limma. 36 Normalized voom counts were then used to test cases versus control subjects in nonstimulated samples by using linear modeling, including batch effects of site, sex, and year of blood draw. A linear model was built containing group (case vs control subject), stimulation (nonstimulation and cockroach stimulation), site, sex, year of blood draw, and home allergen levels (Bla g 1 in the bedroom and living room) and a random effect for the subject to test differences between cases and control subjects in response to cockroach stimulation. The equivalent was done for DM stimulation but with nonstimulation, DM stimulation, and Der f 1 and Der p 1 levels in the bedroom and living room. Where cell-specific gene sets were tested rather than individual genes, the geometric mean of all the genes within the set was used as a summary expression for the mixed-effect linear model. Multiple testing correction was done by using the Benjamini-Hochberg procedure, controlling the false discovery rate (FDR) at a level of 0.05.
Cell deconvolution to assess which cell types significantly affect gene expression was performed by using the Immune Response In Silico (IRIS) data set 37 as the reference data set to determine cell-specific marker genes. 38 Marker genes for B cells, DCs, monocytes, NK cells, CD4 1 T cells, and CD8 1 T cells were used. Surrogate cell proportions were calculated for our samples by using the digital sorting algorithm. 39 Finally, genes that were significant for cases versus control subjects in response to stimulation (cockroach or DM) were assigned to cell type by using the Subset Prediction from Enrichment Correlation algorithm. 40 The stability of the gene assignment to cell type was assessed through subsampling the marker genes through 100 iterations. Gene set correlation P values were calculated by simulating random gene sets of equivalent size over 10,000 simulations.
A general linear model was used with a gamma distribution and log link function to calculate a parameter estimate and P value to assess correlations among gene sets and clinical data. For comparisons of clinical and demographic data among groups, P values are calculated as appropriate for data: t test for normally distributed continuous data, Kruskal-Wallis test for nonnormally distributed continuous data, and either the x 2 or Fisher exact test for categorical data.
Pathway analysis
Differentially expressed genes and gene sets were investigated by using Database for Annotation Visualization and Integrated Discovery, version 6.7. 41, 42 This database uses a modified Fisher exact test to identify specific biological/functional categories that are overrepresented in gene sets in comparison with a reference set (the default human genome was used as the reference set). Gene Ontology biological processes, canonical pathways from Kyoto Encyclopedia of Genes and Genomes (KEGG), and pathways from BioCarta that were associated with differentially expressed genes were used as databases.
STRING, version 10.0, which is a database of known and predicted proteinprotein interactions, was used to determine interaction networks of cellspecific gene sets. Default parameters were used, including all interaction sources and using a minimum required interaction score or 0.40 to be included in the network. 43 Cytoscape, version 3.2.1, was used to draw interaction networks according to a prefuse force-directed layout by using the combined interaction score exported from STRING. 44 Unconnected nodes were excluded.
Data and material availability
RNA sequencing data were deposited in the National Center for Biotechnology Information Gene Expression Omnibus with accession number GSE96783.
RESULTS
Increased NK cell-type gene expression is associated with development of allergic asthma
Initially, we focused on 2 groups of children defined by clinical outcome in a nested case-control design (cohort 1). The case group was composed of all URECA participants who had 2 or more aeroallergen sensitizations, including DM, cockroach, or both, at ages 3, 5, and 7 years and had a diagnosis of asthma at age 7 years. We defined this group as having early-onset multiple sensitizations and asthma (Early group, n 5 21). The control group (Neither group, n 5 30) was composed of URECA participants who had no aeroallergen sensitization at age 3, 5, or 7 years and did not have asthma at age 7 years. These subjects were matched to the Early group according to demographic variables and allergen exposure in the home. RNA sequencing was performed on the year 2 nonstimulated, cockroach-stimulated, DM-stimulated, and TTstimulated samples from these 51 subjects.
The Early group differed clinically from the Neither group, with a higher incidence of wheezing illnesses and higher Eczema Area and Severity Index scores in the first year of life, which are known risk factors for asthma development. At age 2 years, the time of blood draw, they had higher total IgE levels and higher specific IgE levels to food and airborne allergens, although most specific IgE levels were less than the cutoff for definition of sensitization (< _0.35 kU/L). By age 7 years, these same clinical differences were more pronounced, and the IgE levels markedly increased and demonstrated multiple specific sensitizations (see Table E1 in this article's Online Repository at www.jacionline.org).
Principal component analysis of gene expression of unstimulated PBMCs from these 2 groups showed similar global patterns among subjects (Fig 1, A) . The primary source of variability in gene expression was city of residence (site); all 4 sites were represented equally in both groups. Assessment for differentially expressed genes comparing the Early and Neither groups while controlling for site demonstrated a small set of differentially expressed genes (13 genes at FDR < 0.05 and 131 genes at FDR < 0.25) between the groups, the majority of which (13/13 and 110/131, respectively) were expressed at a higher level in the Early group (Fig 1, B) . The upregulated genes were highly enriched for NK cell-specific genes and no other cell type from the IRIS reference data set (Fig 1, C) , 37 as well as the KEGG 45, 46 pathway NK cell-mediated cytotoxicity (FDR 5 2.7E-6). Gene expression of PBMCs from the same subjects after stimulation with the control antigen TT (to which all children had been vaccinated) demonstrated robust gene expression changes caused by stimulation (see Fig E2, A, in this article's Online Repository at www.jacionline.org) and no significant differences in gene expression between groups after stimulation (Fig 1, D) , documenting a similar peripheral immune response to this common antigen to which children have uniform exposure. These results demonstrate that children with early-onset multiple sensitizations and asthma have greater gene expression of NK cell-related genes in resting PBMCs at age 2 years relative to matched control subjects but show similar responses to stimulation with a common vaccine antigen.
Allergen stimulation causes NK cell-and T H 2-like gene activation
We next examined the cockroach-and DM-stimulated samples in cohort 1. Among all subjects, each allergen stimulation showed robust global gene expression relative to unstimulated samples (see Fig E2, B and C) . The type of stimulation accounted for the greatest amount of variability among these samples, and each allergen stimulation showed a relatively distinct pattern of global gene expression (Fig 2, A) .
Of the 21 Early group subjects, the 16 with cockroach sensitization by age 3 years (CR-Early group) demonstrated significant differences in expression of 206 genes in response to cockroach stimulation compared with the Neither group (FDR < 0.05; Fig 2, B) . Similarly the 13 Early group subjects who were DM sensitized by age 3 years (DM-Early group) demonstrated significantly different expression of 91 genes in response to DM stimulation compared with the Neither group (FDR < 0.05; Fig  2, C) . No genes were expressed differentially among the samples in association with total or allergen-specific IgE levels at age 2 years in linear models. Furthermore, a similar pattern of gene expression differences was observed between children in the Early group stratified by allergen sensitization at age 2 years, demonstrating these findings are independent of whether the Early group subjects were already sensitized at the time of blood draw.
The cockroach-and DM-induced gene lists showed enrichment for the same Gene Ontology biologic processes: immune response, cell proliferation, and programmed cell death. Genes in each of these pathways showed increased expression with both allergen stimulations in the Early group relative to the Neither group (Fig 2,  B and C) . These 2 gene lists, which are derived from different subsets of subjects and are induced by different allergen stimulations, show highly significant overlap (P 5 3.6E-75, Fisher exact test ;  Fig 2, D) , suggesting the observed responses represent a common molecular response to allergen stimulation in susceptible subjects. Of all the 244 genes differentially expressed in the combined gene list, we focused on the 213 that showed increased expression in the Early group relative to the Neither group with both allergen stimulations (see Table E2 in this article's Online Repository at www.jacionline.org). None of these 213 genes were expressed differentially between groups after TT stimulation.
The set of allergen-upregulated genes specific to the Early group contains the same 13 genes that showed greater expression in the unstimulated samples (Fig 2, D) ; all these genes were upregulated further by allergen stimulation in the Early group (see Table E2 ). These 213 genes include numerous additional NK cell-related genes (FDR 5 6.9E-21 for IRIS NK cell marker genes and FDR 5 2.8E-6 for KEGG NK cell-mediated cytotoxicity), as well as several cytokine-signaling genes (FDR 5 7.5E-4 for KEGG cytokine-cytokine receptor interaction), including multiple signaling genes implicated in T H 2-type inflammation, such as IL9, IL13, CCL17, CCL5, and CCR4.
NK cells and DCs represent a primary source of response to allergen
The primary cellular source of the 244 differentially expressed gene transcripts was assessed by means of computational deconvolution with established markers for 6 major cell types contained in PBMCs (see Table E3 in this article's Online Repository at www.jacionline.org). 40, 47 One hundred eight of these 244 differentially expressed genes could be assigned to NK cells and were not associated with other cell types available for deconvolution (Fig 3, A , and see Fig E3 in this article's Online Repository at www.jacionline.org). All of these NK cell-assigned genes were increased in expression after cockroach or DM stimulation in the Early group compared with the Neither group. These NK cell-associated genes show a high level of gene-gene correlation (r 5 0.31, P <.0001) and as a gene set show a coherent increase in expression level with both cockroach and DM stimulation in the Early group but not the Neither group (Fig 3, B) .
These NK cell-associated genes represent a densely clustered network of known gene-gene interactions and associations (Fig 3, C) and are enriched for the KEGG pathway NK cell-mediated cytotoxicity (FDR 5 2.0E-5), cytokine-cytokine receptor interaction (FDR 5 3.4E-5), antigen processing and presentation (FDR 5 3.9E-5), and the chemokine signaling pathway (FDR 5 5.3E-2). The NK cell-type response includes both T H 1-and T H 2-type inflammatory genes but shows a particularly high increase in the critical T H 2 inflammatory cytokines IL9, IL13, and CCL17 (Fig 3, D) , suggesting that NK cell-derived T H 2 cytokines might be a principal source of skewing toward T H 2 inflammation at this developmental stage of the immune system. In contrast, expression of CD4 1 T cell-assigned genes was decreased predominantly by allergen stimulation (see Table E3 ) and was not correlated with levels of these T H 2 inflammatory cytokines.
A separate set of 52 of the 244 differentially expressed genes showed an expression pattern highly correlated with DC marker genes and not with other cell types (Fig 3, A, and see Fig E3) . These DC-associated genes show a high level of gene-gene correlation (r 5 0.53, P <.0001) and a moderate increase in response to cockroach allergen stimulation specific to the CR-Early group and not seen in the Neither group (see Fig E4, A, in this article's Online Repository at www.jacionline.org). In contrast, the DC gene response to DM stimulation was not significant in the DM-Early subjects (see Fig E4, B) . These DC-associated genes form a smaller network of known gene-gene interactions (see Fig E4, C) but do not show significant pathway-specific enrichment. The observed DC gene set includes the important lipid antigen-presenting genes CD1B and CD1E, both of which were induced highly by cockroach stimulation in the CR-Early group and also show an increase with DM stimulation in the DM-Early group (see Fig E4, D) .
The remaining differentially expressed genes show correlations with B-cell, CD4
1 T-cell, CD8 1 T-cell, and monocyte marker genes, but they form smaller gene sets and do not show enrichment for known molecular pathways. As gene sets, they show relatively modest differences between the Early and Neither groups with stimulation. The relevance of these differences is less evident and could either represent changes in cell composition, uncharacterized molecular pathways, or functional pathways that this study is underpowered to detect.
NK cell-type response is specific to allergy and asthma development
To assess the reproducibility of our findings and the specificity to the development of both allergy and asthma, we investigated the response to stimulation in an independently selected group of URECA participants (cohort 2). Cohort 1 focused on subjects with the most severe phenotype of interest, specifically those with multiple sensitizations by age 3 years and asthma by age 7 years. There were no additional URECA participants who met these selection criteria; however, there were participants with cockroach sensitization between ages 3 and 7 years and asthma by age 7 years. Seven such subjects were identified: 3 became cockroach sensitized by age 5 years, and the other 4 became cockroach sensitized by age 7 years; 6 of 7 had multiple allergic sensitizations at age 7 years. This group was considered to have late allergy and asthma onset (Late group) and was compared with 14 newly selected and matched Neither group subject who did not experience allergic A, The 244 genes could each be assigned to 1 of the 6 cell subsets by using marker gene cell deconvolution. Sensitivity analysis showed that gene assignments were relatively stable over 100 bootstrap simulations (Subset Prediction from Enrichment Correlation sensitivity analysis). B, The NK cell gene set shows significantly greater baseline expression in the Early group compared with the Neither group, which increases significantly with allergen stimulation in both the CR-Early and DM-Early groups; bounds represent 95% CIs (stimulation linear models with fixed effects for site, sex, year of blood draw, home allergen levels, and stimulation; random effect for individual subject; P value and fold change [FC] represent group term controlling for stimulation). C, NK cell genes represent a densely connected network of known gene-gene interactions. D, Box plot of normalized expression of IL9, IL13, and CCL17 showing group differences with allergen stimulation (pink, CR-Early group; blue, DM-Early group; gray, Neither group). CR, Cockroach. sensitization or asthma by age 7 years. Despite the later onset of allergen sensitization, a similar difference in gene expression was observed in PBMCs collected at age 2 years. In the Late group compared with the Neither group, unstimulated PBMCs and those stimulated with cockroach extract overexpressed the same NK cell gene set that was exhibited by the Early group (Fig 4, A and B) . A difference in the DC gene set was not observed in this cohort.
We next tested whether NK cell expression was related to allergy, asthma, or both. Children from the CR-Early and Late groups were combined with a single group (n 5 20), and their nonstimulated and cockroach-stimulated gene expression data were compared with those of other subgroups of URECA participants classified by outcome at age 7 years: those with cockroach sensitization without asthma (n 5 35), those with asthma without any allergic sensitization (n 5 40), and those with neither allergic sensitization nor asthma (n 5 102, see Table E4 in this article's Online Repository at www.jacionline. org). Increased NK cell gene expression at age 2 years was found only in children with both cockroach sensitization and asthma by age 7 years (Fig 4, C and D) . Notably, similar results were found for increased expression of the DC gene set after cockroach stimulation (see Fig E4, E) . The other 3 groups were indistinguishable from one another in expression of NK and DC gene sets.
To better understand the cause of this NK cell gene set response among the Early and Late groups, we investigated the correlation of multiple clinical variables with NK cell gene set expression. The demographic variable that most highly correlated with expression level of the NK cell gene set was home cockroach allergen level measured in the first year of life. Among these 20 subjects, a higher level of cockroach exposure correlated with a higher level of NK cell gene set expression in response to cockroach stimulation (Fig 4, E) . Home allergen levels did not correlate with NK cell gene expression within the other 3 groups. This finding suggests these disease-susceptible subjects might have an NK response directly influenced by higher levels of allergen exposure early in life.
DISCUSSION
Children with multiple allergies in early life have an increased risk for wheezing and asthma. To identify immunologic correlates of early multiple allergic sensitization and asthma in high-risk urban children participating in the URECA study, we analyzed patterns of allergen-specific gene expression at age 2 years and compared these findings with longitudinal patterns of allergic sensitization and asthma assessed through age 7 years. Our results reveal differential gene expression in unstimulated and allergenstimulated PBMCs collected at age 2 years in children with early multiple sensitization followed by asthma. Affected children exhibited increased expression of NK cell-related genes in unstimulated PBMCs, and differential expression of these NK cell-related genes was augmented by stimulation with cockroach and DM allergen but not TT. The largest set of differentially expressed genes after allergen stimulation was attributed to NK cells through cell marker deconvolution. This gene set describes a densely interconnected gene-gene interaction network that likely represents expansion of NK cells or a similar population of cytotoxic lymphocytes, as well as activation of these cells, leading to transcription of key immune signaling molecules, including the canonical T H 2 cytokines IL-9, IL-13, and CCL17. We also observed an upregulation of DC-related genes, including CD1 lipid presentation molecules, with cockroach stimulation.
Our results suggest that NK cell-like innate immune responses in early life contribute to development of aeroallergen sensitization-driven asthma. Mouse models have demonstrated a key role for NK cells in allergy and asthma development, and lack of NK cells attenuates airway inflammation in allergensensitized mice. 23, 24, 48, 49 Furthermore, children and adults with asthma have previously been observed to have higher levels of NK cells than nonasthmatic subjects after disease onset, 28, [50] [51] [52] and NK cells are a known source of T H 2 cytokines. 53, 54 Specifically, subpopulations of NK cells from adults with asthma have been shown to produce T H 2 cytokines 55 and also to directly regulate T-cell activation. 56 Our results are among the first evidence that NK cell-type responses in early life appear to play a direct role in the development of allergic asthma in children.
We have also found evidence of upregulation of lipid antigen presentation by DCs in response to cockroach, which is coincident with the observed NK cell response. Bidirectional NK-DC cross-talk can modify the differentiation of memory CD4
1 T-cell responses. [57] [58] [59] In mouse models NK cells can also induce maturation of DCs and regulate their participation in allergen presentation and allergic sensitization. 23, [60] [61] [62] Our data implicate immune responses related to both NK cells and DCs in earlylife immunopathogenesis, leading to allergic asthma.
Having observed the NK cell-and DC-type responses within this nested case-control cohort, we were able to demonstrate the same NK cell finding in a second group of children with allergic sensitization after age 3 years. Furthermore, we showed the specificity of these findings to children who have aeroallergen sensitization with asthma compared with those with only one of the conditions. Thus our results suggest that increased expression of NK-related genes occurs before allergic sensitization and predisposes specifically to asthma associated with allergic sensitization.
NK cells and DCs can differ intrinsically in children with allergic sensitization and asthma or might be modulated early in life by environmental factors. Given that these children tend to have more wheezing illnesses and viral respiratory tract infections in early life, as observed here and in previous work, 63 one possible mechanism is recruitment of NK cells from the periphery to the lung during those infections, as suggested by findings in adults with asthma, 64 where they could skew toward type 2 inflammation. However, viral infection alone seems insufficient to drive this NK signature because it was lacking in the group with asthma without allergic sensitization despite those subjects also having a higher incidence of early-life wheezing illnesses (see Table E4 ). We observed that among children with disease, the magnitude of the NK cell-type response correlated with cockroach allergen levels in house dust, suggesting allergen or associated exposures might play a key role in this immune response. Because cockroach allergen is also a marker of specific microbial exposures and the cockroach extract used in this study contains endotoxins and other bacterial components, it is possible that the microbial environment of these children also contributes to the observed immune response in light of known associations between the microbiome and disease development in this population. 65, 66 Whether NK cell responses are shaped by environmental, genetic, or epigenetic differences is under investigation. We have also not yet determined how NK cell responses change longitudinally during immune development and manifestation of clinical disease among these children. Assessing each of these factors will be critical to better understanding the mechanisms by which NK cells can contribute to disease development, improving identification of at-risk children early in life and ultimately identifying disease prevention strategies.
We used computational cell deconvolution to assess the source of the gene expression differences observed. A distinct advantage to assessing immune responses by using this method in a cell mixture is the ability to observe global expression patterns along with cell specificity and to infer potential cell-cell interactions. 47 However, although the gene sets described show high correlation with NK and DC cell marker genes, this assignment is probabilistic and limited by the ability to resolve cell types by patterns of marker gene expression in a complex mixture. Cells with highly similar transcriptional profiles, including NK cells, iNKT cells, and gd T cells, could each be contributing in part to the observed NK cell-type gene expression. In this study only bulk PBMC RNA had been stored, but in future studies, cell sorting followed by population or single-cell RNA sequencing would help resolve the source of the signal with greater specificity.
We conclude that children prone to aeroallergen sensitization and asthma have increased expression of NK cell-related genes in PBMCs in early life that is markedly upregulated on stimulation with allergen but not TT. This gene expression pattern includes transcription of IL9, IL13, CCL17, CCL5, and CCR4, which likely promote skewing toward T H 2 polarization. These findings are supported further by observed upregulation of DC genes after allergen stimulation, including those involved in lipid antigen presentation. These findings provide evidence for a mechanistic link for susceptibility to allergic asthma in high-risk children and suggest potential methods for early disease risk identification and disease prevention. Our findings also have the potential to identify key biomarkers for allergic asthma development, which will be necessary to conduct population-targeted asthma prevention studies.
